Should the NHS be mixing vaccines for better effect, or at least offering people who have had one dose of the AstraZeneca vaccine the choice of having the Pfizer vaccine for their second shot?
The question arises because that is exactly the regime which has been followed in Germany since the risk of clotting from the AstraZeneca vaccine became evident.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in